Conclusion
In conclusion, further investigations on IgG4-RND patients should be
performed, focusing on the diagnosis. Early recognition of IgG4-RND can
help avoid system dysfunction and disability in the nervous system and
other organs of the body due to its potential for guiding the diagnosis
of other co-occurring conditions. We should include it in the
differential diagnosis of possible cases because despite responding to
treatments, its potential risks are as of yet unknown.
References
1. Stone JH, Zen Y, Deshpande V. IgG4-Related Disease. New England
Journal of Medicine. 2012;366(6):539-551.
2. Nilles C, Poillon G, Deschamps L, et al. IgG4-related pachymeningitis
and mastoiditis, associated with cerebral venous thrombosis: A case
report. Journal of Neuroimmunology. 2021;360:577717.
3. Deshpande V, Zen Y, Chan JKC, et al. Consensus statement on the
pathology of IgG4-related disease. Modern Pathology.2012;25(9):1181-1192.
4. Vasaitis L. IgG4-related disease: A relatively new concept for
clinicians. European Journal of Internal Medicine. 2016;27:1-9.
5. Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of
Rheumatology/European League Against Rheumatism Classification Criteria
for IgG4-Related Disease. Arthritis & rheumatology (Hoboken,
NJ). 2020;72(1):7-19.
6. AbdelRazek MA, Venna N, Stone JH. IgG4-related disease of the central
and peripheral nervous systems. The Lancet Neurology.2018;17(2):183-192.
7. Perez FA. Imaging of Nontraumatic Orbital and Neuro-ophthalmological
Emergencies. Paper presented at: Seminars in Roentgenology2020.
8. Shimatsu A, Oki Y, Fujisawa I, Sano T. Pituitary and stalk lesions
(infundibulo-hypophysitis) associated with immunoglobulin G4-related
systemic disease: an emerging clinical entity. Endocrine journal.2009;56(9):1033-1041.
9. Ekizoglu E, Coban O, Ulukan C, et al. Intracranial hypertension
related to cerebral venous thrombosis; and acute ischemic stroke with
micro-infarcts associated with IgG4-related disease. International
Journal of Neuroscience. 2018;128(11):1097-1099.
10. Joshi D, Jager R, Hurel S, et al. Cerebral involvement in
IgG4-related disease. Clin Med (Lond). 2015;15(2):130-134.
11. Liu Y, Xue F, Yang J, Zhang Y. Immunoglobulin G4-related disease
mimicking lymphoma in a Chinese patient. Rheumatology
International. 2015;35(10):1749-1752.
12. Lu LX, Della-Torre E, Stone JH, Clark SW. IgG4-Related Hypertrophic
Pachymeningitis: Clinical Features, Diagnostic Criteria, and Treatment.JAMA Neurology. 2014;71(6):785-793.
13. Fujita A, Sakai O, Chapman MN, Sugimoto H. IgG4-related Disease of
the Head and Neck: CT and MR Imaging Manifestations.RadioGraphics. 2012;32(7):1945-1958.
14. Della-Torre E, Galli L, Franciotta D, et al. Diagnostic value of
IgG4 Indices in IgG4-related hypertrophic pachymeningitis. Journal
of neuroimmunology. 2014;266(1-2):82-86.
15. Liu A, Zhang Q, Liu B, Xu N, Li A. A case of immunoglobulin
G4-related lung disease with bilateral diffuse infiltration: A case
report. Medicine (Baltimore). 2017;96(50):e9211.
16. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations
in patients with sclerosing pancreatitis. N Engl J Med.2001;344(10):732-738.
17. Blockmans D. IgG4-related disease. Acta Clin Belg.2018;73(1):11-15.
18. Sireesha Y, Uppin MS, Ganti S, et al. A Series of Biopsy-proven
Patients with Immunoglobulin G4-related Neurological Disease. Ann
Indian Acad Neurol. 2019;22(1):73-78.
19. Baptista B, Casian A, Gunawardena H, D’Cruz D, Rice CM. Neurological
Manifestations of IgG4-Related Disease. Curr Treat Options
Neurol. 2017;19(4):14.
20. Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset
of 235 consecutive patients. Medicine (Baltimore).2015;94(15):e680.
21. Lin W, Lu S, Chen H, et al. Clinical characteristics of
immunoglobulin G4-related disease: a prospective study of 118 Chinese
patients. Rheumatology (Oxford). 2015;54(11):1982-1990.
22. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J
Med. 2012;366(6):539-551.
23. Vasaitis L. IgG4-related disease: A relatively new concept for
clinicians. Eur J Intern Med. 2016;27:1-9.